Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.8.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2018
Mar. 31, 2017
CURRENT ASSETS    
Cash $ 6,974,070 $ 1,559,701
Accounts receivable 74,813 0
Prepaid expenses and other current assets 181,367 37,551
TOTAL CURRENT ASSETS 7,230,250 1,597,252
Property and equipment, net 27,552 29,223
Patents, net 75,832 84,996
Deposits 18,270 14,897
TOTAL ASSETS 7,351,904 1,726,368
CURRENT LIABILITIES    
Accounts payable 124,450 484,423
Due to related parties 90,366 57,866
Other current liabilities 263,141 69,467
TOTAL CURRENT LIABILITIES 477,957 611,756
Convertible notes payable, net 841,153 519,200
TOTAL LIABILITIES 1,319,110 1,130,956
COMMITMENTS AND CONTINGENCIES (Note 12)
STOCKHOLDERS' EQUITY    
Common stock, $0.001 par value, 30,000,000 shares authorized at March 31, 2018 and 2017; 17,739,511 and 8,797,086 issued and outstanding at March 31, 2018 and 2017, respectively 17,740 8,796
Additional paid-in capital 105,574,014 94,445,739
Accumulated deficit (99,457,714) (93,778,156)
TOTAL AETHLON MEDICAL, INC. STOCKHOLDERS' EQUITY BEFORE NONCONTROLLING INTERESTS 6,134,040 676,379
NONCONTROLLING INTERESTS (101,246) (80,967)
TOTAL STOCKHOLDERS' EQUITY 6,032,794 595,412
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 7,351,904 $ 1,726,368